Cipher Capital LP Has $5.34 Million Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Cipher Capital LP cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 45.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 69,179 shares of the pharmacy operator’s stock after selling 57,705 shares during the period. Cipher Capital LP’s holdings in Walgreens Boots Alliance were worth $5,342,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after buying an additional 1,926,108 shares during the period. Franklin Resources Inc. increased its stake in shares of Walgreens Boots Alliance by 24.7% during the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares during the last quarter. Nordea Investment Management AB increased its stake in shares of Walgreens Boots Alliance by 10.2% during the 2nd quarter. Nordea Investment Management AB now owns 10,085,836 shares of the pharmacy operator’s stock worth $789,822,000 after purchasing an additional 931,508 shares during the last quarter. CI Global Investments Inc. increased its stake in shares of Walgreens Boots Alliance by 4.8% during the 2nd quarter. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator’s stock worth $464,503,000 after purchasing an additional 270,182 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Walgreens Boots Alliance by 14.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,905,909 shares of the pharmacy operator’s stock worth $462,500,000 after purchasing an additional 741,875 shares during the last quarter. 61.18% of the stock is owned by institutional investors and hedge funds.

In other Walgreens Boots Alliance news, Director John Anthony Lederer purchased 20,000 shares of the stock in a transaction dated Thursday, October 26th. The stock was bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 14.80% of the company’s stock.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $76.07 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The firm has a market cap of $75,340.00, a PE ratio of 21.01, a price-to-earnings-growth ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.10 EPS. equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.67 earnings per share for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Several research analysts have recently commented on WBA shares. Pivotal Research dropped their price target on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research note on Tuesday, October 24th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. Deutsche Bank assumed coverage on shares of Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 price target for the company. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Finally, Royal Bank of Canada reissued a “buy” rating and issued a $88.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. Nine analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $86.20.

COPYRIGHT VIOLATION WARNING: This article was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.thelincolnianonline.com/2018/01/14/cipher-capital-lp-cuts-stake-in-walgreens-boots-alliance-inc-wba-updated-updated.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply